Susquehanna International Group
AIM

Susquehanna International Group’s AIM ImmunoTech AIM Stock Holding History

Susquehanna International Group’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-381
Closed -$7.53K – 13841
2024
Q4 		$7.53K Buy
+381
New +$8.88K ﹤0.01% 11996
2024
Q2 		– Sell
-168
Closed -$7.93K – 13638
2024
Q1 		$7.93K Buy
168
+16
+11% +$663 ﹤0.01% 11927
2023
Q4 		$6.69K Buy
+152
New +$7.09K ﹤0.01% 12109
2023
Q3 		– Sell
-547
Closed -$36.6K – 13532
2023
Q2 		$36.6K Buy
547
+447
+447% +$21.6K ﹤0.01% 11454
2023
Q1 		$4.3K Sell
100
-241
-71% -$12.5K ﹤0.01% 12321
2022
Q4 		$10.6K Buy
341
+51
+18% +$2.37K ﹤0.01% 11931
2022
Q3 		$17K Buy
290
+99
+52% +$6.93K ﹤0.01% 12665
2022
Q2 		$15K Buy
+191
New +$18.3K ﹤0.01% 12435
2022
Q1 		– Sell
-378
Closed -$35K – 14705
2021
Q4 		$35K Buy
378
+16
+4% +$2.47K ﹤0.01% 12706
2021
Q3 		$73K Buy
+362
New +$73.1K ﹤0.01% 12211
2020
Q3 		– Sell
-253
Closed -$63K – 11604
2020
Q2 		$63K Buy
+253
New +$61.4K ﹤0.01% 9692
2019
Q1 		– Sell
-14
Closed -$11K – 10685
2018
Q4 		$11K Buy
14
+9
+180% +$8.26K ﹤0.01% 8744
2018
Q3 		$6K Buy
+5
New +$6.1K ﹤0.01% 9061
2018
Q1 		– Sell
-12
Closed -$18K – 10979
2017
Q4 		$18K Buy
12
+1
+9% +$1.44K ﹤0.01% 9082
2017
Q3 		$16K Buy
+11
New +$19.3K ﹤0.01% 8670
2017
Q2 		– Sell
-9
Closed -$22K – 10525
2017
Q1 		$22K Sell
9
-4
-31% -$10.2K ﹤0.01% 8723
2016
Q4 		$39K Buy
+13
New +$52.4K ﹤0.01% 9346
2016
Q2 		– Sell
-2
Closed -$12K – 10178
2016
Q1 		$12K Buy
+2
New +$12.8K ﹤0.01% 8872

Other funds holding AIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group's AIM Position: Q1 2025 in Review

Susquehanna International Group sold out of AIM ImmunoTech (AIM) in Q1 2025, closing a stake of 381 shares — an estimated $7.53K sold.

Susquehanna International Group first reported a position in AIM in Q1 2016 and held it in 18 quarters. The position peaked at $73K in Q3 2021. 32 funds tracked by Wall St. Rank hold AIM as of Q1 2025.

  • Susquehanna International Group reported no remaining AIM ImmunoTech position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 381 AIM ImmunoTech shares in Q1 2025, an estimated $7.53K.
  • Susquehanna International Group first reported a position in AIM ImmunoTech in Q1 2016 and held it in 18 quarters.
  • Susquehanna International Group's AIM ImmunoTech position peaked at $73K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.